American Diabetes Association
Browse
DC22-1786 Online_Appendix_revised_for_DC.pdf (1.05 MB)

Treatment of Gestational Diabetes and Maternal Risk of Diabetes after Pregnancy

Download (1.05 MB)
figure
posted on 2023-01-05, 13:51 authored by Ravi Retnakaran, Chang YE, Anthony J. Hanley, Philip W. Connelly, Mathew Sermer, Bernard Zinman

  

Objective: To compare postpartum glucose tolerance between women treated for gestational diabetes (GDM) and those not treated.
Methods: Metabolic testing was performed at 3-months and 1-year postpartum in 599 women comprising the following gestational glucose tolerance groups: (I) normal glucose challenge test (GCT) and oral glucose tolerance test (OGTT) in pregnancy; (II) abnormal GCT with normal OGTT; (III) gestational impaired glucose tolerance; (IV) mild untreated GDM; and (V) severe treated GDM.
Results: Birthweight progressively increased across Groups I-IV, before falling steeply in treated GDM (p<0.0001). In contrast, at 3-months and 1-year, insulin sensitivity and beta-cell function progressively decreased across the 5 groups, mirrored by rising fasting and 2-hour glucose (all p<0.0001). Accordingly, prevalence of pre-diabetes/diabetes at 1-year increased in a stepwise manner across Groups I-V (2.8%, 9.6%, 13.5%, 21.5%, 32.6%; p<0.0001).
Conclusion: Treating GDM lowers birthweight but does not disrupt the association between gestational glycemia and maternal pre-diabetes/diabetes after pregnancy.

Funding

Canadian Institutes of Health Research (CIHR) x MOP-84206 PJT-156286

History